COMMUNIQUÉS West-GlobeNewswire

Sanofi et Regeneron annoncent les résultats positifs des premières études consacrées à l'évaluation de Praluent® (alirocumab) chez des personnes présentant un diabète et une hypercholestérolémie
11/06/2017
Sanofi et Regeneron annoncent les résultats positifs des premières études consacrées à l'évaluation de Praluent ® (alirocumab) chez des personnes présentant un diabète et une hypercholestérolémie - Les données de ces [...]
New analysis shows Soliqua® 100/33 lowered HbA1c by more than 2% in patients with screening levels greater than 9%
10/06/2017
Pressrelease - No. 6/2017 New analysis shows Soliqua ® 100/33 lowered HbA 1c by more than 2% in patients with screening levels greater than 9% All subgroups treated with Soliqua ® 100/33 achieved a mean HbA 1c of less [...]
Dasiglucagon (pINN) presentation at the 77th Scientific Sessions of the American Diabetes Association (ADA) indicate use for treatment of severe hypoglycemia
10/06/2017
Press Release - No. 5/2017 Dasiglucagon (pINN) presentation at the 77th Scientific Sessions of the American Diabetes Association (ADA) indicate use for treatment of severe hypoglycemia Elaborated results from Phase 2 [...]
XBiotech Announces Discontinuation of Phase III Study for Colorectal Cancer Based on Second Interim Analysis
09/06/2017
AUSTIN, Texas, June 09, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today that an Independent Data Monitoring Committee (IDMC) has performed its second prospectively planned, unblinded analysis of the [...]
Medable Launches Synapse, a Fully Integrated Clinical Care App Platform Using CareKit
09/06/2017
Medable's next generation disease management solution seeks to significantly improve health outcomes through provider and patient directed apps that track and trend patient health in real-time PALO ALTO, Calif., June 09 [...]
Medable lance Synapse, une plateforme d'application de soins cliniques intégralement intégrée utilisant CareKit
09/06/2017
La solution de gestion des maladies de la prochaine génération de Medable vise à améliorer significativement les résultats en matière de santé grâce à des applications destinées aux prestataires de soins et aux patients [...]
Publication of Idorsia's prospectus relating to the listing of Idorsia Ltd on SIX Swiss Exchange
09/06/2017
ALLSCHWIL/BASEL, SWITZERLAND - 09 June 2017 - Actelion Ltd (SIX:ATLN) today published the listing prospectus relating to the listing of Idorsia shares on SIX Swiss Exchange. With the tender offer for all publicly held [...]
Johnson & Johnson announces expected settlement of Actelion tender offer on June 16, 2017
09/06/2017
Announces receipt of all regulatory approvals required to complete acquisition of Actelion ALLSCHWIL/BASEL, SWITZERLAND - 09 June 2017 - Johnson & Johnson (NYSE:JNJ) today announced that, with today's receipt of [...]
Targovax ASA: Notice of Extraordinary General Meeting
09/06/2017
An Extraordinary General Meeting of Targovax ASA will be held at the Company's offices at Lysaker, on 30 June 2017 at 09:00 CET. Please find the notice including agenda for the Extraordinary General Meeting and [...]
Sixth Annual HOOPP LEAP Awards Honours Property Managers and Tenants for Outstanding Performance, Collaboration and Innovation
09/06/2017
TORONTO, June 09, 2017 (GLOBE NEWSWIRE) -- The Healthcare of Ontario Pension Plan (HOOPP) once again reinforced its role as a global leader in real estate sustainability practices by honouring property managers and [...]
La sixième cérémonie annuelle de remise des prix HOOPP LEAP honore les gestionnaires immobiliers et les locataires pour un rendement, une collaboration et une innovation exceptionnels
09/06/2017
TORONTO, le 9 juin 2017 (GLOBE NEWSWIRE) - Le Healthcare of Ontario Pension Plan (HOOPP) a de nouveau renforcé son rôle de leader mondial dans les pratiques de durabilité immobilière en honorant les gestionnaires [...]
Targovax ASA - Information on the subsequent offering - Key date information
09/06/2017
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]
Mithra Pharmaceuticals: MITHRA RECEIVES ORPHAN DRUG DESIGNATION FROM EMA FOR E4 IN NEONATAL ENCEPHALOPATHY
09/06/2017
PRESS RELEASE Mithra RECEIVES ORPHAN DRUG DESIGNATION FROM EMA FOR E4 IN NEONATAL ENCEPHALOPATHY Orphan Drug Designation received from European Medicines Agency for Estetrol (E4) in the treatment of life-threatening [...]
KISSEI TO MARKET AVACOPAN IN JAPAN FOR VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA
09/06/2017
PRESS RELEASE This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]
NICOX : Issuing and admission to trading on the Euronext regulated market in Paris of 597,897 new shares awarded to former Aciex shareholders following the US FDA's approval of ZERVIATE
09/06/2017
Press release This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]
Communiqué rectificatif: Emission et admission aux négociations sur le marché réglementé d'Euronext à Paris de 597.897 actions nouvelles attribuées aux anciens actionnaires d'Aciex suite à l'approb...
09/06/2017
Communiqué de presse This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for [...]
TARGOVAX ASA - SUCCESSFULLY COMPLETED PRIVATE PLACEMENT
08/06/2017
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]
Novartis presents data demonstrating efficacy of AMG 334 (erenumab) in migraine prevention at the American Headache Society Annual Meeting
08/06/2017
Data from the comprehensive clinical program show AMG 334 (erenumab) is safe and effective at preventing migraine in patients with 4 or more migraine days per month AMG 334 (erenumab) significantly reduced monthly [...]
Nicox: Emission et admission aux négociations sur le marché réglementé d'Euronext à Paris de 597 897 actions nouvelles attribuées aux anciens actionnaires d'Aciex suite à l'approbation du ZERVIATE
08/06/2017
Communiqué de presse Nicox annonce l'émission et l'admission aux négociations sur le marché réglementé d'Euronext à Paris de 597.897 actions nouvelles attribuées aux anciens actionnaires d'Aciex suite à l'approbation [...]

Pages